mephenytoin and cycloguanil

mephenytoin has been researched along with cycloguanil in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (90.00)18.2507
2000's0 (0.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Bosco, O; Funck-Brentano, C; Jacqz-Aigrain, E; Jaillon, P; Keundjian, A1
Breckenridge, AM; Brøsen, K; Gram, LF; Helsby, NA; Skjelbo, E; Ward, SA1
Funck-Brentano, C; Jacqz-Aigrain, E; Jaillon, P; Keundjian, A; Partovian, C1
Chiba, K; Darmansjah, I; Ishizaki, T; Kusaka, M; Setiabudy, R1
Brøsen, K; Flachs, H; Skjelbo, E1
Chiba, K; Ishizaki, T; Kusaka, M; Setiabudy, R1
Brøsen, K; Jeppesen, U; Rasmussen, BB1
Bochner, F; Coller, JK; Somogyi, AA1
Bathum, L; Brøsen, K; Hørder, M; Madsen, H; Mutabingwa, TK; Skjelbo, E1

Trials

3 trial(s) available for mephenytoin and cycloguanil

ArticleYear
Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans.
    Clinical pharmacology and therapeutics, 1992, Volume: 51, Issue:5

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 Enzyme System; Dextromethorphan; Female; Humans; Hydroxylation; Male; Mephenytoin; Polymorphism, Genetic; Prodrugs; Proguanil; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Triazines

1992
Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans.
    Clinical pharmacology and therapeutics, 1995, Volume: 58, Issue:3

    Topics: Adult; Cross-Over Studies; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; Isoenzymes; Male; Mephenytoin; Omeprazole; Proguanil; Triazines

1995
Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanide.
    Clinical pharmacology and therapeutics, 1997, Volume: 62, Issue:3

    Topics: Administration, Oral; Adult; Antimetabolites; Aryl Hydrocarbon Hydroxylases; Biguanides; Biotransformation; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Fluvoxamine; Folic Acid Antagonists; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Proguanil; Selective Serotonin Reuptake Inhibitors; Triazines

1997

Other Studies

7 other study(ies) available for mephenytoin and cycloguanil

ArticleYear
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel study.
    British journal of clinical pharmacology, 1991, Volume: 31, Issue:6

    Topics: Adult; Female; Humans; Male; Mephenytoin; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Proguanil; Reference Values; Sparteine; Triazines

1991
Metabolic disposition of proguanil in extensive and poor metabolisers of S-mephenytoin 4'-hydroxylation recruited from an Indonesian population.
    British journal of clinical pharmacology, 1995, Volume: 39, Issue:3

    Topics: Adult; Biguanides; Chromatography, High Pressure Liquid; Cohort Studies; Female; Half-Life; Humans; Hydroxylation; Indonesia; Male; Mephenytoin; Middle Aged; Polymorphism, Genetic; Proguanil; Regression Analysis; Triazines

1995
Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark.
    British journal of clinical pharmacology, 1993, Volume: 36, Issue:2

    Topics: Administration, Oral; Adult; Biguanides; Denmark; Female; Humans; Male; Mephenytoin; Middle Aged; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Proguanil; Sparteine; Triazines; Vietnam

1993
Simultaneous measurement of proguanil and its metabolites in human plasma and urine by reversed-phase high-performance liquid chromatography, and its preliminary application in relation to genetically determined S-mephenytoin 4'-hydroxylation status.
    The American journal of tropical medicine and hygiene, 1996, Volume: 54, Issue:2

    Topics: Adult; Antimalarials; Biguanides; Chromatography, High Pressure Liquid; Humans; Hydroxylation; Male; Mephenytoin; Middle Aged; Phenotype; Proguanil; Triazines

1996
Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.
    British journal of clinical pharmacology, 1999, Volume: 48, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal; Anticonvulsants; Antimetabolites; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; Folic Acid Antagonists; Genotype; Humans; In Vitro Techniques; Isoenzymes; Male; Mephenytoin; Microsomes, Liver; Middle Aged; Oxidation-Reduction; Proguanil; Triazines

1999
Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population.
    British journal of clinical pharmacology, 1999, Volume: 48, Issue:3

    Topics: Adult; Alleles; Aryl Hydrocarbon Hydroxylases; Black People; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Female; Genetic Variation; Genetics, Population; Genotype; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Phenotype; Proguanil; Sparteine; Tanzania; Triazines

1999